Gerresheimer AG: Dr. Christian Fischer resigns as CEO of Gerresheimer AG
February 05, 2018 at 02:00 pm EST
Share
DGAP-Ad-hoc: Gerresheimer AG / Key word(s): Change of Personnel
Gerresheimer AG: Dr. Christian Fischer resigns as CEO of Gerresheimer AG
05-Feb-2018 / 19:54 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Dr. Christian Fischer resigns as CEO of Gerresheimer AG
Düsseldorf, February 05, 2018
Dr. Christian Fischer, Chairman of the Management Board of Gerresheimer AG, will leave the Company with immediate effect. Dr. Fischer has asked for an amicable premature termination of his services due to personal reasons. Such decision is not based on diverging views regarding the strategy or business performance of the Company. The Supervisory Board has accepted such request. The Company will be managed by the remaining three board members until a new CEO has been appointed. The CFO Rainer Beaujean will assume the function of Speaker of the Management Board for the interim period. Andreas Schütte continues to lead the Plastics & Devices Division. Dr. Lukas Burkhardt has taken over responsibility for the Primary Packaging Glass Division since January 01, 2018.
05-Feb-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language:
English
Company:
Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Düsseldorf
Germany
Phone:
+49-(0)211/61 81-00
Fax:
+49-(0)211/61 81-295
E-mail:
s.camp@gerresheimer.com
Internet:
http://www.gerresheimer.com
ISIN:
DE000A0LD6E6, XS0626028566
WKN:
A0LD6E, A1H3VP
Indices:
MDAX (Aktie)
Listed:
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
GERRESHEIMER AG 
